5 results
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
anticoagulants (DOACs ... anticoagulant; LMWH ... body mass index; VTE ... #DOAC #VTE #Malignancy ... Management #Hematology #Oncology
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
algorithm for VTE ... risk of recurrent VTE ... DOAC, direct oral ... #DOAC #VTE #Malignancy ... Management #Hematology #Oncology
Heparin, Fondaparinux, and Novel Oral Anticoagulants - Pathophysiology

Anticoagulation with parenteral (intravenous or subcutaneous) and oral anticoagulants
the mainstay of VTE ... . heparin, LMWH, ... anticoagulant (e.g ... #UFH #DOAC #Dabigatran ... #Fondaparinux #NOAC
Summary of Coagulation Deficiencies
Inherited:
 • Hemophilia A - Deficiency of Factor VIII
 • Hemophilia B -
Malabsorption (e.g ... Medications - Heparin, LMWH ... , warfarin, DOACs ... (e.g. direct factor ... Autoimmune disorders (e.g
Peripartum Cardiomyopathy - Summary
1. Definition
 • Towards the end of pregnancy to 5 months postpartum
cardiomyopathy (e.g ... Avoid Warfarin and DOAC ... hemodynamics (e.g ... LVEF recovery (e.g ... Serial TTE and close